Founded in 2018, IDOVEN is a European deep-tech company developing artificial intelligence to transform cardiac diagnosis and care. Its work centres on advancing early detection and precision medicine for cardiovascular diseases through deep learning applied to electrocardiogram (ECG) analysis.
The company's flagship product, Willem, is the world's first CE-marked cardiology-as-a-service platform powered by AI. This cloud-based system analyses ECGs from any device, enabling clinicians to detect 22 cardiac patterns and four key intervals - including P, PR, QT and QRS - at scale. Its technical foundation draws on a proprietary dataset of over 1.8 million ECG hours and clinical data from more than 28,500 trial subjects.
IDOVEN's research output includes 35 publications in top-tier scientific journals, reflecting a commitment to peer-reviewed rigour alongside product development. The company operates across Europe, positioning itself at the intersection of healthcare, life sciences and MedTech.
